Screener
LivaNova LIVN Cardiopulmonary — CapEx
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:SegmentExpenditureAdditionToLongLivedAssets.
The source filing: LivaNova’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 2:23 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001639691-26-000090
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Cardiopulmonary | $12,531 | $8,767 | $22,940 | $13,936 |
| Neuromodulation | 7,780 | 4,217 | 16,623 | 6,250 |
| Other capital expenditures (1) | 7,286 | 4,389 | 11,695 | 7,491 |
| $27,597 | $17,373 | $51,258 | $27,677 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is LivaNova's cardiopulmonary — capex?
- LivaNova (LIVN) reported cardiopulmonary — capex of $12.53M in Q2 2026.
- How has LivaNova's cardiopulmonary — capex changed year-over-year?
- LivaNova's cardiopulmonary — capex increased by 42.9% year-over-year, from $8.77M to $12.53M.
- What is the long-term trend for LivaNova's cardiopulmonary — capex?
- Over 4 years (2021 to 2025), LivaNova's cardiopulmonary — capex has grown at a 31.6% compound annual growth rate (CAGR), from $14.82M to $44.51M.
- What does cardiopulmonary — capex mean?
- Measures the funds used by the cardiopulmonary segment to acquire, upgrade, or maintain physical assets such as manufacturing facilities and specialized equipment. It indicates the level of investment in infrastructure necessary to sustain or expand production capacity.
Ask your AI about LivaNova's cardiopulmonary — capex.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude